These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21426102)

  • 1. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR; Maeyer MD; Debyser Z; Christ F
    Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to HIV-1 integrase inhibitors: A structural perspective.
    Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
    Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches for inhibiting HIV integrase: a journey beyond the active site.
    Walker MA
    Curr Opin Investig Drugs; 2009 Feb; 10(2):129-36. PubMed ID: 19197790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance.
    Loizidou EZ; Zeinalipour-Yazdi CD; Christofides T; Kostrikis LG
    Bioorg Med Chem; 2009 Jul; 17(13):4806-18. PubMed ID: 19450984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
    De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
    ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 integrase inhibitors: a review of their chemical development.
    Ingale KB; Bhatia MS
    Antivir Chem Chemother; 2011 Nov; 22(3):95-105. PubMed ID: 22095518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 integrase inhibitors: 2007-2008 update.
    Ramkumar K; Serrao E; Odde S; Neamati N
    Med Res Rev; 2010 Nov; 30(6):890-954. PubMed ID: 20135632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrase inhibitors in the treatment of HIV-1 infection.
    Powderly WG
    J Antimicrob Chemother; 2010 Dec; 65(12):2485-8. PubMed ID: 20852268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New first and second generation inhibitors of human immunodeficiency virus-1 integrase.
    Pendri A; Meanwell NA; Peese KM; Walker MA
    Expert Opin Ther Pat; 2011 Aug; 21(8):1173-89. PubMed ID: 21599420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 integrase inhibitors: 2005-2006 update.
    Dayam R; Gundla R; Al-Mawsawi LQ; Neamati N
    Med Res Rev; 2008 Jan; 28(1):118-54. PubMed ID: 17979144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors.
    Demeulemeester J; Tintori C; Botta M; Debyser Z; Christ F
    J Biomol Screen; 2012 Jun; 17(5):618-28. PubMed ID: 22337657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
    Sippel M; Sotriffer CA
    J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of integrase inhibitors of HIV-1.
    Malet I; Calvez V; Marcelin AG
    Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and analysis of inhibitors of the human immunodeficiency integrase.
    Hazuda D; Felock PJ; Hastings JC; Pramanik B; Wolfe AL
    Drug Des Discov; 1997 May; 15(1):17-24. PubMed ID: 9332828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy.
    McColl DJ; Chen X
    Antiviral Res; 2010 Jan; 85(1):101-18. PubMed ID: 19925830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.